Malta - English - Medicines Authority

the mentholatum company limited - ethyl salicylate, hydroxyethyl salicylate, methyl nicotinate, methyl salicylate - cutaneous spray, solution - ethyl salicylate 5 percent weight/weight ; hydroxyethyl salicylate 5 percent weight/weight ; methyl nicotinate 1.6 percent weight/weight ; methyl salicylate 1 percent weight/weight - topical products for joint and muscular pain

Ireland - English - HPRA (Health Products Regulatory Authority)

the mentholatum company ltd. - methyl nicotinate; hydroxyethyl salicylate ; methyl salicylate; ethyl salicylate - cutaneous spray, solution - unknown - preparations with salicylic acid derivatives

Kenya - English - Pharmacy and Poisons Board

the mentholatum co. ltd. the mentholatum co. ltd. 1 redwood avenue peel - methyl salicylate methyl nicotinate ethyl… - transdermal spray, solution - methyl salicylate 1.0%w/w methyl nicotinate… - other topical products for joint and muscular pain

Ireland - English - HPRA (Health Products Regulatory Authority)

the mentholatum company (ireland) limited - ethyl salicylate; hydroxyethyl salicylate ; methyl salicylate; methyl nicotinate - cutaneous spray, solution - preparations with salicylic acid derivatives

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - menthol 60 mg in 1 ml - carefully consider the potential benefits and risks of nabumetone tablets, usp and other treatment options before deciding to use nabumetone tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). nabumetone tablets, usp are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis. nabumetone tablets are contraindicated in patients with known hypersensitivity to nabumetone or its excipients. nabumetone tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings: anaphylactoid reactions: , and precautions: general: pre-existing asthma:) nabumetone tablets are contraindicated in the setting of coronary artery bypass graft (cabg) surgery (see warnings ). topical an

United States - English - NLM (National Library of Medicine)

health specialty.com - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - menthol 10 g in 100 g

Malta - English - Medicines Authority

the mentholatum company (ireland) limited ground floor, 71 lower baggot street dublin, d02 p593 , ireland - cutaneous spray, solution - ethyl salicylate 5 % (w/w) hydroxyethyl salicylate 5 % (w/w) methyl nicotinate 1.6 % (w/w) methyl salicylate 1 % (w/w) - topical products for joint and muscular pain

Malta - English - Medicines Authority

colep laupheim gmbh & co.kg fockestrasse 12, 88471 laupheim, germany - ethyl salicylate, hydroxyethyl salicylate, methyl nicotinate, methyl salicylate - cutaneous spray, solution - ethyl salicylate 5 % (w/w) hydroxyethyl salicylate 5 % (w/w) methyl nicotinate 1.6 % (w/w) methyl salicylate 1 % (w/w) - topical products for joint and muscular pain

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

mentholatum south africa - spray - see ingredients - each 100 g contains ethyl salicylate 4,95 g glycol salicylate 4,95 g methyl nicotinate 1,59 g methyl salicylate 0,99 g

United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - capsaicin 0.25 mg in 1 ml - carefully consider the potential benefits and risks of ibuprofentablets and other treatment options before deciding to use ibuprofen.use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals (see warnings ). ibu tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. ibu tablets are indicated for relief of mild to moderate pain. ibu tablets are also indicated for the treatment of primary dysmenorrhea. controlled clinical trials to establish the safety and effectiveness of ibu tablets in children have not been conducted. ibu tablets are contraindicated in patients with known hypersensitivityto ibuprofen. ibu tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin orother nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and pr